Chronic kidney disease

Pollack CV Jr, Arroyo D, Kanda E, Lázaro IJS, Lesén E, Franzén S, Gray CM, Lipińska A, Murohara T, Rastogi A. Duration of sodium zirconium[...]

Rhee CM, Gianchandani RY, Kerr D, Philis-Tsimikas A, Kovesdy CP, Stanton RC, Drincic AT, Galindo RJ, Kalantar-Zadeh K, Neumiller JJ, de Boer IH, Lind M,[...]

Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P. Utilization of Potassium Binders for the Management of Hyperkalemia[...]

Nicholas SB, Correa-Rotter R, Desai NR, Guo L, Navaneethan SD, Pantalone KM, Wanner C, Hamacher S, Fatoba ST, Horvat-Broecker A, Garreta-Rufas A, Gay A, Merz[...]

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of[...]

Sluiter A, van Zwieten A, Shen JI, Manera K. Measuring Social Functioning in Chronic Kidney Disease. Semin Nephrol. 2024 Aug 29:151547. doi: 10.1016/j.semnephrol.2024.151547. Epub ahead[...]

Tian L, Jaeger BC, Scialla JJ, Budoff MJ, Mehta RC, Jaar BG, Saab G, Dobre MA, Reilly MP, Rader DJ, Townsend RR, Lash JP, Greenland[...]

Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in[...]

Galindo RJ, Soliman D, Cherñasvvky D, Rhee CM. Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244-y.[...]

Gutiérrez-Peredo GB, Silva Martins MT, da Silva FA, Lopes MB, Lopes GB, James SA, Norris KC, Lopes AA. Fatigue by the Chalder Questionnaire and post-hemodialysis[...]